Novel way to prevent blindness caused by retinitis pigmentosaJune 12th, 2010 - 4:29 pm ICT by ANI
Washington, June 12 (ANI): Scientists have discovered a novel way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa.
The research, led by Muna Naash, at the University of Oklahoma Health Sciences Center, with collaborators in Cleveland and Buffalo, discovered a way to deliver known gene therapies directly to the light-sensitive cells affected by this disease.
The discovery already is being used to develop new treatments for another disease - macular degeneration, the leading cause of blindness in the United States.
“I am thrilled about it. That’s why we have been working so hard to get this as quickly as possible through the necessary experiments, so we can publish our findings and take it out to the patients,” Naash said.
“We hope the results of our study will be instrumental in generating a cure for the debilitating blindness associated with retinitis pigmentosa and other inherited and acquired retinal diseases. We want to give Oklahomans and others suffering from these diseases renewed independence and quality of life,” Naash added.
Utilizing nanoparticle technology, scientists created a microscopic capsule capable of carrying genetic therapies to their destination inside cells of the retina.
The tiny delivery vehicle is being tested with a variety of gene therapies in animal models with the potential of treating several diseases from bladder cancer to diabetes.
The capsules have proven very effective, carrying therapies to the designated location in the eye within 15 minutes of delivery and spreading the genetic repair message quickly to nearby cells.
Robert E. Leonard, an ophthalmologist at the Dean McGee Eye Institute, said: “This is an incredible breakthrough in terms of being able to treat with gene therapy. Outside of gene therapy, we are at a loss to be able to treat these patients, so this is incredibly important research.”
The study appears in the Journal of the Federation of American Societies for Experimental Biology (FASEB). (ANI)
- Compound likely to regenerate vision in humans - Jul 26, 2012
- London hospital to do Europe's first embryonic stem cell trial - Sep 24, 2011
- Novel cell therapy slows down vision loss in eye disease - Apr 08, 2011
- Scientists create retina from human embryonic stem cells - May 27, 2010
- Drugs to treat age-related blindness - Feb 07, 2011
- Fetal tissue helps restore partial vision in the blind - Oct 21, 2009
- Astonishing bionic enables blind to see - Nov 22, 2011
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Bionic eye can restore lost vision - Nov 03, 2010
- Potential cure for vision diseases that lead to terminal blindness found - Aug 05, 2010
- Stem cell therapy may help restore sight in retinitis pigmentosa sufferers - Feb 25, 2010
- Indian origin scientist's gene therapy shows promise in slowing AMD - Apr 30, 2011
- Gene therapy to treat blindness on the anvil - Aug 01, 2009
- Study sheds light on inherited retinal disease - Jan 18, 2010
- Neoretina offers advanced surgery - Jan 19, 2012
Tags: animal models, bladder cancer, dean mcgee eye institute, delivery vehicle, gene therapies, gene therapy, genetic therapies, health sciences center, important research, leading cause of blindness, light sensitive cells, naash, nearby cells, oklahoma health sciences, oklahoma health sciences center, oklahomans, ophthalmologist, retinal diseases, retinitis pigmentosa, university of oklahoma health sciences center